Design & Build

Services

Fairjourney Biologics


FairJourney Biologics, a biotechnology company, entrusted Garcia Garcia with the design & build of its new research centre, in Porto.

Located in front of Avenida AEP, one of the main entry arteries to the city of Porto, it shapes the city entry with its irreverent façade, marked by the imposing three-dimensional white concrete prefabricated panels that point to the scientific activity of the company.
This new centre will provide FairJourney’s employees with all the conditions necessary for carrying out their professional activity in this new centre, with fully equipped laboratories, as well as leisure areas to promote their well-being.
The focus is on the 140 laboratories, the foyer, the social areas and the various outdoor patios scattered around the building and its façade, providing the opportunity for small garden spaces to be discovered. The building has a total of seven floors, three below ground level and four above.

Year

2021

Total Floor Area

8100

Location

Porto

Lead Time

20 months

© 2018 Garcia Garcia SA - 3402- PUB. All rights reserved.
Cookies Settings

GARCIA GARCIA may use cookies to store your login information, collect statistics to optimize site functionality, and perform marketing actions based on your interests.

These cookies are required to enable the site's primary functionality and are automatically enabled when you use this site.
These cookies are required to enable the site's primary functionality and are automatically enabled when you use this site.
They allow you to be in touch with your social network, share content, send and post comments.

Necessary Cookies These cookies are required to enable the site's primary functionality and are automatically enabled when you use this site.

Funtional Cookier These cookies are required to enable the site's primary functionality and are automatically enabled when you use this site.

Advertisement Cookies They allow you to be in touch with your social network, share content, send and post comments.